1. Home
  2. RMBS vs CRL Comparison

RMBS vs CRL Comparison

Compare RMBS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rambus Inc.

RMBS

Rambus Inc.

HOLD

Current Price

$134.05

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$169.41

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBS
CRL
Founded
1990
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.0B
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
RMBS
CRL
Price
$134.05
$169.41
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$137.00
$198.27
AVG Volume (30 Days)
2.4M
711.6K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.88
N/A
EPS
0.55
N/A
Revenue
$707,630,000.00
$1,857,601,000.00
Revenue This Year
$16.01
N/A
Revenue Next Year
$16.23
$3.04
P/E Ratio
$234.94
N/A
Revenue Growth
27.13
10.48
52 Week Low
$52.18
$132.58
52 Week High
$161.80
$228.88

Technical Indicators

Market Signals
Indicator
RMBS
CRL
Relative Strength Index (RSI) 59.86 45.96
Support Level $90.31 $161.39
Resistance Level $161.80 $184.75
Average True Range (ATR) 9.22 8.05
MACD -0.26 0.09
Stochastic Oscillator 51.57 22.85

Price Performance

Historical Comparison
RMBS
CRL

About RMBS Rambus Inc.

Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: